Evidence map›Paper›PMID 22101728›Full record

ArticleNature immunology2011

Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus.

Nadine Honke, Namir Shaabani, Giuseppe Cadeddu, Ursula R Sorg, Dong-Er Zhang, Mirko Trilling, Karin Klingel, Martina Sauter, Reinhard Kandolf, Nicole Gailus and 12 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 227 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Newly identified oncolytic VSV-GP-specific CD8Molecular therapy. Oncology · 2025
    Article
  10. Article
  11. Article
  12. Exploring CD169Vaccines · 2025
    Review
  13. Article
  14. VSVNature communications · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 5 countries.

Nadine HonkeDepartment of Gastroenterology, Hepatology and Infectious Diseases, Heinrich-Heine-University, Düsseldorf, Germany.
Namir Shaabani
Giuseppe Cadeddu
Ursula R Sorg
Dong-Er Zhang
Mirko Trilling
Karin Klingel
Martina Sauter
Reinhard Kandolf
Nicole Gailus
Nico van Rooijen
Christoph Burkart
Stephan E Baldus
Melanie Grusdat
Max Löhning
Hartmut Hengel
Klaus Pfeffer
Masato Tanaka
Dieter Häussinger
Mike Recher
Philipp A Lang
Karl S Lang
Heinrich Heine University Düsseldorf · DEUniversity of Tübingen · DEUniversity of California, San Diego · USGerman Rheumatism Research Centre · DEHarvard University · USOntario Institute for Cancer Research · CARIKEN Center for Integrative Medical Sciences · JPVrije Universiteit Amsterdam · NL

Funding

UBP43 in HematopoiesisR01HL091549 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZHANG, DONG-ER · 2008 to 2012
$1.9M
NHLBI NIH HHS R01 HL091549
6 · The paper itself

Abstract

The innate immune system limits viral replication via type I interferon and also induces the presentation of viral antigens to cells of the adaptive immune response. Using infection of mice with vesicular stomatitis virus, we analyzed how the innate immune system inhibits viral propagation but still allows the presentation of antigen to cells of the adaptive immune response. We found that expression of the gene encoding the inhibitory protein Usp18 in metallophilic macrophages led to lower type I interferon responsiveness, thereby allowing locally restricted replication of virus. This was essential for the induction of adaptive antiviral immune responses and, therefore, for preventing the fatal outcome of infection. In conclusion, we found that enforced viral replication in marginal zone macrophages was an immunological mechanism that ensured the production of sufficient antigen for effective activation of the adaptive immune response.

Indexed as

Adaptive ImmunityAnimalsAntigen PresentationAntigens, ViralCell Line, TransformedCricetinaeDendritic CellsEndopeptidasesLymphotoxin beta ReceptorMacrophagesMembrane GlycoproteinsMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutReceptors, ImmunologicAntigens, ViralEndopeptidasesLymphotoxin beta ReceptorMembrane GlycoproteinsReceptors, ImmunologicSialic Acid Binding Ig-like Lectin 1Siglec1 protein, mouseUbiquitin ThiolesteraseUsp18 protein, mouse

Identifiers

PMID22101728
OpenAlexW1965916060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.